The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study-Reference-Cited by-同舟云学术

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

Published:2016-11-21 Issue:4 Volume:52 Page:520-533
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kumada Hiromitsu,Suzuki Yoshiyuki,Karino Yoshiyasu,Chayama Kazuaki,Kawada Norifumi,Okanoue Takeshi,Itoh Yoshito,Mochida Satoshi,Toyoda Hidenori,Yoshiji Hitoshi,Takaki Shintaro,Yatsuzuka Naoyoshi,Yodoya Etsuo,Iwasa Takashi,Fujimoto Go,Robertson Michael N.,Black Stuart,Caro Luzelena,Wahl Janice

Funder

Merck

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-016-1285-y.pdf

Reference20 articles.

1. Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(Suppl 1):S45–57.

2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107–15.

3. Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology. 2010;53(1):39–43.